Story thread · 2 reports / 2 sources

Lilly CEO Eyes Bigger Deals in Hunt for Pharma’s ‘White Spaces’

bloomberg.com · 5h · first reportShare

Investors should expect Eli Lilly & Co. to strike slightly larger deals, along the lines of its $7.8 billion acquisition of Centessa Pharmaceuticals Plc, as it casts a wide net for assets in the “white spaces” of science, Chief Executive Officer Dave Ricks said.